These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 12686552)
41. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling. Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129 [TBL] [Abstract][Full Text] [Related]
42. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction. Kuang C; Chen Y Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410 [TBL] [Abstract][Full Text] [Related]
43. Regulation of MCP-1 gene transcription by Smads and HIV-1 Tat in human glial cells. Abraham S; Sawaya BE; Safak M; Batuman O; Khalili K; Amini S Virology; 2003 May; 309(2):196-202. PubMed ID: 12758167 [TBL] [Abstract][Full Text] [Related]
44. Specificity in transforming growth factor beta-induced transcription of the plasminogen activator inhibitor-1 gene: interactions of promoter DNA, transcription factor muE3, and Smad proteins. Hua X; Miller ZA; Wu G; Shi Y; Lodish HF Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13130-5. PubMed ID: 10557285 [TBL] [Abstract][Full Text] [Related]
45. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells. Poncelet AC; Schnaper HW J Biol Chem; 2001 Mar; 276(10):6983-92. PubMed ID: 11114293 [TBL] [Abstract][Full Text] [Related]
46. Both Max and TFE3 cooperate with Smad proteins to bind the plasminogen activator inhibitor-1 promoter, but they have opposite effects on transcriptional activity. Grinberg AV; Kerppola T J Biol Chem; 2003 Mar; 278(13):11227-36. PubMed ID: 12551947 [TBL] [Abstract][Full Text] [Related]
47. Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-beta signaling. Imoto S; Sugiyama K; Sekine Y; Matsuda T FEBS Lett; 2005 May; 579(13):2853-62. PubMed ID: 15907489 [TBL] [Abstract][Full Text] [Related]
48. The L3 loop and C-terminal phosphorylation jointly define Smad protein trimerization. Chacko BM; Qin B; Correia JJ; Lam SS; de Caestecker MP; Lin K Nat Struct Biol; 2001 Mar; 8(3):248-53. PubMed ID: 11224571 [TBL] [Abstract][Full Text] [Related]
49. Differential ubiquitination defines the functional status of the tumor suppressor Smad4. Morén A; Hellman U; Inada Y; Imamura T; Heldin CH; Moustakas A J Biol Chem; 2003 Aug; 278(35):33571-82. PubMed ID: 12794086 [TBL] [Abstract][Full Text] [Related]
50. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. Pardali K; Kurisaki A; Morén A; ten Dijke P; Kardassis D; Moustakas A J Biol Chem; 2000 Sep; 275(38):29244-56. PubMed ID: 10878024 [TBL] [Abstract][Full Text] [Related]
51. Structural comparison of the PhoB and OmpR DNA-binding/transactivation domains and the arrangement of PhoB molecules on the phosphate box. Okamura H; Hanaoka S; Nagadoi A; Makino K; Nishimura Y J Mol Biol; 2000 Feb; 295(5):1225-36. PubMed ID: 10653699 [TBL] [Abstract][Full Text] [Related]
52. Human Smad3 and Smad4 are sequence-specific transcription activators. Zawel L; Dai JL; Buckhaults P; Zhou S; Kinzler KW; Vogelstein B; Kern SE Mol Cell; 1998 Mar; 1(4):611-7. PubMed ID: 9660945 [TBL] [Abstract][Full Text] [Related]
53. Transforming growth factor-beta inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors. Li C; Zhu NL; Tan RC; Ballard PL; Derynck R; Minoo P J Biol Chem; 2002 Oct; 277(41):38399-408. PubMed ID: 12161428 [TBL] [Abstract][Full Text] [Related]
54. Homology modeling of the DNA-binding domain of human Smad5: a molecular model for inhibitor design. Hariharan R; Pillai MR J Mol Graph Model; 2006 Jan; 24(4):271-7. PubMed ID: 16243555 [TBL] [Abstract][Full Text] [Related]
55. Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4. Lin X; Liang M; Liang YY; Brunicardi FC; Melchior F; Feng XH J Biol Chem; 2003 May; 278(21):18714-9. PubMed ID: 12621041 [TBL] [Abstract][Full Text] [Related]
56. Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner. Verrecchia F; Vindevoghel L; Lechleider RJ; Uitto J; Roberts AB; Mauviel A Oncogene; 2001 Jun; 20(26):3332-40. PubMed ID: 11423983 [TBL] [Abstract][Full Text] [Related]
57. Hepatitis B Virus X Protein Function Requires Zinc Binding. Ramakrishnan D; Xing W; Beran RK; Chemuru S; Rohrs H; Niedziela-Majka A; Marchand B; Mehra U; Zábranský A; Doležal M; Hubálek M; Pichová I; Gross ML; Kwon HJ; Fletcher SP J Virol; 2019 Aug; 93(16):. PubMed ID: 31167910 [TBL] [Abstract][Full Text] [Related]
58. Structure of an Ebf1:DNA complex reveals unusual DNA recognition and structural homology with Rel proteins. Treiber N; Treiber T; Zocher G; Grosschedl R Genes Dev; 2010 Oct; 24(20):2270-5. PubMed ID: 20876732 [TBL] [Abstract][Full Text] [Related]
59. Physical and functional interaction between GATA-3 and Smad3 allows TGF-beta regulation of GATA target genes. Blokzijl A; ten Dijke P; Ibáñez CF Curr Biol; 2002 Jan; 12(1):35-45. PubMed ID: 11790301 [TBL] [Abstract][Full Text] [Related]
60. Structure of the GCM domain-DNA complex: a DNA-binding domain with a novel fold and mode of target site recognition. Cohen SX; Moulin M; Hashemolhosseini S; Kilian K; Wegner M; Müller CW EMBO J; 2003 Apr; 22(8):1835-45. PubMed ID: 12682016 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]